What is the Bionesp 40 mcg?

What is Bionesp 40 mcg

Bionesp 40 mcg consists of the active ingredient Darbepoetin alfa, which is a structural and functional analogue of erythropoietin, which is essential for the production of red blood cells (RBCs). This drug is mainly indicated for the treatment of anemia caused by chronic kidney disease or chemotherapy treatments.

What are the Uses of Bionesp 40 mcg?

What are the Dosage Guidelines for Bionesp 40 mcg?

1. Anemia due to Chronic Kidney Disease (CKD)

Recommended dose:

• CKD patients on dialysis:
• 0.45 mcg/kg once a week, OR 
• 0.75 mcg/kg every 2 weeks given through intravenous (IV) or subcutaneous (SC)
• CKD patients not on dialysis:
• 0.45 mcg/kg once every 4 weeks given through intravenous (IV) or subcutaneous (SC)
• Dose adjustments:
• Increase the dose by 25% if the rise in Hb is lower than 1 g/dL after 4 weeks
• Reduce the dose by ≥25% if the rise in Hb is more than 1 g/dL in 2 weeks
• Keep a minimum gap of 4 weeks between dose adjustments.

Maximum dose limit:

• There is no fixed maximum dose limit. 
• Clinicians must administer the lowest effective concentration.

Missed dose instructions:

• If a dose of Bionesp 40 mcg is missed, administer the missed dose as soon as possible.
• If the time is close to the next dose, skip the dose and follow the normal dosing schedule.

Overdose instructions:

• Overdose of Bionesp 40 mcg can cause an excessive rise in hemoglobin, thromboembolic, and cardiovascular events.
• In such cases, clinicians must temporarily halt the administration of this drug and provide supportive care.

2. Chemotherapy-Induced Anemia in Cancer

Recommended dose

• Option 1: 
• 2.25 mcg/kg once a week, given subcutaneously
• Option 2: 
  • 500 mcg once every 3 weeks, given subcutaneously
  • This dosage must be initiated only when the hemoglobin is less than 10 g/dL, and there is at least 2 weeks of chemotherapy planned.
  • Dose adjustments:
    • Reduce the dose by 40% if the rise in Hb is less than 1 g/dL in 2 weeks.
    • Increase the dose to 4.5 mcg/kg/week if there is an inadequate response after 6 weeks

Maximum dose limit:

• There is no fixed maximum dose limit. 
• Clinicians must administer the lowest effective concentration.

Missed dose instructions:

• If a dose of Bionesp 40 mcg is missed, administer the missed dose as soon as possible.
• If the time is close to the next dose, skip the dose and follow the normal dosing schedule.

Overdose instructions:

• Overdose of Bionesp 40 mcg can cause an excessive rise in hemoglobin, thromboembolic, and cardiovascular events.
• In such cases, clinicians must temporarily halt the administration of this drug and provide supportive care.

You can buy Bionesp 40 mcg injection from Lifesaving-meds.com at low price online with free shipping & free sample medicines. Lifesaving-meds.com provide Bionesp 40 mcg at very less wholesale price for sale from India with low price guarantee, big discounts, free delivery,  credit card / debit card, Zellepay, paypal, crypto / Bitcoin payment option & more in the United states of America (USA) – New York, California, Texas, Florida, Ohio, Oregon, Georgia, Denver, Illinois, Oregon, Pennsylvania, Washington, Wyoming & more; United Kingdom (UK) – London, Birmingham, Wales, Manchester & more; Europe (EU) – Moscow (Russia), Paris (France), Spain & more; and Australia (AU) – Sydney, Melbourne, Brisbane & more. So, buy  Bionesp 40 mcg injection near you when you are prescribed with this medication or search as Bionesp 40 mcg for sale near me on google, bing, yahoo, duckducko, AOL & anywhere.

How does Bionesp 40 mcg Work?

In certain cases (such as CKD and patients under chemotherapy), the kidneys are unable to produce enough Erythropoietin (EPO). EPO is the hormone that facilitates the production of RBCs by stimulating the erythroid precursor cells in the bone marrow. In patients with impaired bone marrow function, there is a reduced number of activated erythroid precursor cells, which results in a decreased amount of oxygen being delivered to the tissues due to the resultant anemia.

Bionesp 40 mcg (Darbepoetin alfa) is a long-acting, synthetic analog of Erythropoietin, which binds to the EPO receptor on the erythroid precursor cells in the bone marrow. This activates the intracellular signal transduction pathways (primarily the JAK2-STAT pathway), which promotes erythroid precursor cell proliferation and differentiation into RBCs. This drug inhibits apoptosis and promotes the survival of the RBCs.

Bionesp 40 mcg increases the transcription of genes necessary for hemoglobin production and RBC maturation. In this way, this drug promotes an increased number of RBCs in the blood, increased hemoglobin levels, and improved tissue oxygenation.

What are the Side Effects of Bionesp 40 mcg?

Common Side Effects

• Hypertension (high blood pressure)
• Headache
• Fatigue
• Edema (swelling of legs or arms)
• Nausea and vomiting
• Diarrhea
• Injection site reactions (pain, redness, swelling)
• Fever

Hematologic Effects

• Increased hemoglobin levels
• Risk of thromboembolic events (blood clots)
  • Deep vein thrombosis (DVT)
  • Pulmonary embolism
  • Increased blood viscosity/

Cardiovascular Effects

• Worsening hypertension
• Stroke
• Myocardial infarction (heart attack)
• Heart failure exacerbation

Neurological Effects

• Seizures (especially during a rapid rise in hemoglobin)
• Dizziness

Dermatological Effects

• Rash
• Pruritus (itching)

Serious but Rare Side Effects

• Pure red cell aplasia (PRCA) – severe anemia due to antibody formation
• Severe allergic reactions (anaphylaxis, angioedema)
• Stevens-Johnson syndrome (very rare but serious skin reaction)

Cancer-Related Concerns

• Tumor progression or reduced survival in some cancer patients when used to target high hemoglobin levels

Other Effects

• Flu-like symptoms
• Bone pain
•  

What are the Precautions Bionesp 40 mcg?

The administration of Bionesp 40 mcg must be decided based on the patient’s hemoglobin levels. 

• The hemoglobin levels must be maintained at 11 g/dL (at most) while on Bionesp 40 mcg.
• Avoid an abrupt rise of hemoglobin ( >1 g/dL in 2 weeks) while on Bionesp 40 mg therapy.
• Patients must be regularly monitored for thromboembolic events, allergic reactions, or sudden loss of response.
• If there is no response after 8 weeks of administration, the therapy must be discontinued.

Other Information

Frequently Asked Questions

1.What are the indications treated using Bionesp 40 mcg?

Bionesp 40 mcg is mainly used for the treatment of anemia caused by certain conditions.

2.How does Bionesp 40 mcg work?

Bionesp 40 mcg works by stimulating the production of RBCs by the bone marrow.

3.How early can the effects of Bionesp 40 mcg be observed?

The effects of Bionesp 40 mcg can be observed within 2-4 weeks.

4.Can Bionesp 40 mcg replace blood transfusions?

This drug can reduce the frequency of blood transfusions but cannot replace them completely.

5.How is this drug administered?

Bionesp 40 mcg is administered subcutaneously or intravenously.